Zhejiang Yatai Pharmaceutical Co., Ltd.
002370.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.56B
Close$
$0.83
82.2% downside
Current Fair Value
82.2% downsideOvervalued by 82.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.56 Billion |
|---|---|
| Enterprise Value | $3.05 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.13 |
| Beta | 0.06 |
| Outstanding Shares | 745,667,530 |
Return
| Return on Equity | -0.83% |
|---|---|
| Return on Assets | -0.78% |
| Return on Invested Capital | -1.43% |
Valuation & Multiples
| P/E Ratio | -370.54 |
|---|---|
| PEG | 377.74 |
| Price to Sales | - |
| Price to Book Ratio | 4.67 |
| Enterprise Value to Revenue | 9.3 |
| Enterprise Value to EBIT | -189.32 |
| Enterprise Value to Net Income | -329 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Zhejiang Yatai Pharmaceutical Co., Ltd.
511 employees
CEO: Qin Shui Tan Zhejiang Yatai Pharmaceutical Co., Ltd. operates across the entire pharmaceutical value chain, encompassing the research, development, manufacturing, sales, and global distribution of its medicinal products. The company's diverse product...